Baird Capital, a venture capital, growth equity and private equity investment firm, is set to invest in Azzur Group, a pharmaceutical, biotechnology, and medical device manufacturer, for $32m. “Baird Capital has a history of investing in pharma services businesses, and we look forward to bringing our resources, relationships, and experiences to support Azzur’s future growth. We are excited to partner with Michael and his strong leadership team to help them build on their past successes," Brett Tucker, Baird Capital Partner.